Granisetron
Serotonin (5ht3) Antagonists
Sold as Sancuso
- Drug class
- Serotonin (5ht3) Antagonists
- Availability
- See label
- Routes
- Intravenous, Oral
- Markets covered
- 3
- Products on record
- 20
Overview
Granisetron is an active pharmaceutical ingredient in the Serotonin (5ht3) Antagonists group (A04AA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 14 | April 17, 2026 |
| CA Canada | Health Canada | 5 | November 26, 2025 |
| EU European Union | EMA | 1 | December 2, 2024 |
GBUnited Kingdom· MHRA
14 products
Uses
Granisetron film coated tablets are indicated in adults for the prevention and treatment of acute nausea and vomiting associated with chemotherapy and radiotherapy. Granisetron film coated tablets are indicated in adults for prevention of delayed nausea and vomiting associated with chemotherapy and radiotherapy.
How to take
CACanada· Health Canada
5 products
Uses
AND CLINICAL USE .................................................................................. 3 CONTRAINDICATIONS ....................................................................................................... 3 WARNINGS AND PRECAUTIONS ......................................................................................
4 ADVERSE REACTIONS ........................................................................................................ 6 DRUG INTERACTIONS ........................................................................................................
8 DOSAGE AND ADMINISTRATION .................................................................................... 9 OVERDOSAGE ....................................................................................................................
10 ACTION AND CLINICAL PHARMACOLOGY ................................................................ 10 STORAGE AND STABILITY .............................................................................................. 12 DOSAGE FORMS, COMPOSITION AND PACKAGING .................................................
EUEuropean Union· EMA
1 product
Uses
1).
How to take
Drug interactions
Known interactions involving Granisetron. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 445. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL366870295 · revised January 10, 2025
- [2]Health Canada (DPD) · 02558408 · revised July 21, 2025
- [3]European Medicines Agency · EMEA/H/C/002296 · revised December 2, 2024
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.